首页> 外文期刊>FEBS letters. >Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.
【24h】

Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.

机译:奥沙利铂通过CBL调节脂质筏中死亡受体的重新分布来增强TRAIL诱导的胃癌细胞凋亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor family that selectively induces apoptosis in cancer cells. However, gastric cancer cells are insensitive to TRAIL. In the present study, we show that oxaliplatin enhanced TRAIL-induced apoptosis of MGC803, BGC823, and SGC7901 cells. Oxaliplatin promoted death receptor 4 (DR4) and death receptor 5 (DR5) clustering into aggregated lipid rafts, while the cholesterol-sequestering agent nystatin partially prevented lipid raft aggregation, DR4 and DR5 clustering, and reduced apoptosis. Furthermore, the expression of the casitas B-lineage lymphoma (Cbl) family was downregulated by oxaliplatin. Transfection of c-Cbl or Cbl-b partially reversed oxaliplatin-induced lipid raft aggregation. These results indicated that oxaliplatin enhanced TRAIL-induced gastric cancer cell apoptosis at least partially through Cbl-regulated death receptor redistribution in lipid rafts.
机译:肿瘤坏死因子相关的凋亡诱导配体(TRAIL)是肿瘤坏死因子家族的成员,其选择性地诱导癌细胞的凋亡。然而,胃癌细胞对TRAIL不敏感。在本研究中,我们表明奥沙利铂增强TRAIL诱导的MGC803,BGC823和SGC7901细胞凋亡。奥沙利铂可促进死亡受体4(DR4)和死亡受体5(DR5)聚集到聚集的脂质筏中,而胆固醇替代剂制霉菌素nystatin可以部分阻止脂质筏聚集,DR4和DR5聚集并减少凋亡。此外,奥沙利铂下调了Casitas B谱系淋巴瘤(Cbl)家族的表达。 c-Cbl或Cbl-b的转染部分逆转了奥沙利铂诱导的脂质筏聚集。这些结果表明,奥沙利铂至少部分地通过脂质筏中Cbl调节的死亡受体的重新分布增强了TRAIL诱导的胃癌细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号